Drugs Made In America Acquisition II Units
DMIIU10.040USD
+0.010+0.10%
Close 03/11, 16:00（ET）Quotes delayed by 15 min
514.05MMarket Cap
--P/E TTM
More Details of Company
Drugs Made In America Acquisition II Units Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Drugs Made In America Acquisition II Units
Name
Name/Position
Position
Shareholding
Change
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn Worman
Mr. Glenn Worman
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director
Independent Director
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director
Independent Director
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director
Independent Director
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Feb 19
Updated: Thu, Feb 19
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
MMCAP Asset Management
4.12%
LMR Partners LLP
3.05%
Healthcare Of Ontario Pension Plan
3.05%
Drugs Made In America Acquisition II LLC
1.07%
Heights Capital Management, Inc.
0.79%
Other
87.92%
Shareholders
Shareholders
Proportion
MMCAP Asset Management
4.12%
LMR Partners LLP
3.05%
Healthcare Of Ontario Pension Plan
3.05%
Drugs Made In America Acquisition II LLC
1.07%
Heights Capital Management, Inc.
0.79%
Other
87.92%
Shareholder Types
Shareholders
Proportion
Hedge Fund
9.74%
Investment Advisor/Hedge Fund
3.30%
Pension Fund
3.05%
Investment Advisor
2.17%
Corporation
1.07%
Other
80.67%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
78
46.21M
0.02%
--
2025Q3
76
45.95M
70.07%
+45.95M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
MMCAP Asset Management
2.70M
4.12%
+2.70M
--
Sep 30, 2025
LMR Partners LLP
2.00M
3.05%
+2.00M
--
Sep 30, 2025
Healthcare Of Ontario Pension Plan
2.00M
3.05%
+2.00M
--
Sep 30, 2025
Millennium Management LLC
2.00M
3.05%
+2.00M
--
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
SPAC and New Issue ETF
0%
SPAC and New Issue ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
